Antacid duration-of-use label warning changes agreed to by NDMA and FDA.
This article was originally published in The Tan Sheet
Executive Summary
NDMA AGREES TO CHANGES IN ANTACIDS' DURATION-OF-USE WARNING at an Aug. 11 "OTC feedback" meeting with FDA regarding use of an antacid for more than two weeks and consultation with a doctor. The new warning proposed by NDMA would read: "Do not take more than [maximum daily dose] in a 24-hour period or use the maximum daily dose for more than two weeks continuously, except under the advice and supervision of a doctor."